For chronic disc-related back pain, a non-surgical regenerative approach now exists that addresses the disc itself. Intra-annular fibrin injection uses an FDA-approved fibrin sealant to seal annular tears so the disc can heal naturally — an outpatient option for patients who have not found lasting relief through conservative care.
Key Takeaways
- Chronic disc pain often stems from annular tears that conservative care cannot close.
- The regenerative approach targets the disc directly.
- Reported 83% long-term success among 7,000+ tracked patients.
- Procedure is outpatient and uses no hardware.
- A clinical evaluation determines candidacy.
What Counts as Chronic Disc-Related Pain?
Pain lasting more than three months that originates from a structural disc problem — most often an annular tear, contained herniation, or disc-related degeneration. Symptoms include pain with sitting or bending, occasional radicular symptoms (leg or arm pain), and recurrent flares despite consistent conservative care.
Why Hasn’t Conservative Care Held?
Conservative therapy reduces inflammation, improves muscular support, and helps tolerate activity. It does not seal annular tears. When the tear is the underlying driver, the cycle of relief and recurrence repeats.
What Does the Regenerative Approach Do Differently?
Under image guidance, an FDA-approved fibrin sealant is placed inside the disc through a thin needle. The sealant fills the annular tear and inner cavity. As it solidifies, it stabilizes the tear, allowing the body’s healing response to progress over the following weeks and months.
Clinical Note
Our clinical staff evaluates every patient to confirm an annular tear is generating the pain before recommending the procedure. Sealing the wrong disc does not help. Sealing the right disc, in the right patient, can change the trajectory of chronic pain that has not responded to other treatments.
Who Is a Candidate?
- Adults with chronic disc-related back or neck pain.
- Confirmed annular tear, contained herniation, or disc-related degeneration.
- Conservative care without lasting relief.
- No spinal instability or progressive neurological deficit.
- Veterans meeting Mission Act criteria.
What Does Recovery Look Like?
Most patients walk out the same day. Activity returns gradually over weeks. Reported VAS scores have improved from 72.4mm baseline to 33.0mm at 104 weeks among the most-tracked outcomes; 70% patient satisfaction at 2+ year follow-up; individual outcomes vary.
Frequently Asked Questions
Is this a stem-cell procedure?
No. It uses an FDA-approved fibrin sealant, not stem-cell or biologic cellular material.
How long does the procedure take?
The procedure itself takes about an hour. Most patients are home a few hours after.
Will I need physical therapy after?
Yes. Continued PT and graded activity support disc healing.
Will the VA pay for this?
Eligible veterans may qualify under the Mission Act. Valor handles the paperwork directly.
Sources & Further Reading
- NIH — Discogenic chronic low back pain
- AAFP — Chronic pain evaluation
- VA — Mission Act
- CDC — Chronic pain
Medical disclaimer: This article is for educational purposes and does not replace medical advice. Consult your physician about any condition or treatment decision.
Schedule a consultation with the Valor team to learn whether the regenerative approach fits your situation.
